Related Experiment Video
Updated: May 10, 2026
06:39
Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
Novel curcumin oral delivery systems.
1Laboratory of Pharmaceutics, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki-city, Kagawa 769-2193, Japan. t-kurita@kph.bunri-u.ac.jp
Anticancer Research
|June 20, 2013
Summary
Curcumin shows promise in cancer research but has poor oral bioavailability. New delivery systems are needed to improve its effectiveness in clinical applications.
Area of Science:
- Pharmacology
- Natural Products
- Cancer Biology
Background:
- Curcumin, a compound from turmeric, impacts cancer cell signaling pathways involved in inflammation, proliferation, and metastasis.
- Despite in vitro efficacy, curcumin's clinical success is limited by poor oral bioavailability due to solubility and pharmacokinetic issues.
Purpose of the Study:
- To review the physicochemical properties and pharmacokinetics of curcumin.
- To discuss recent advancements in oral drug delivery systems for curcumin.
Main Methods:
- Literature review of curcumin's properties.
- Analysis of recent studies on novel curcumin delivery systems.
Main Results:
- Curcumin exhibits broad anticancer activity by modulating key cellular pathways.
- Poor solubility and pharmacokinetics significantly hinder curcumin's oral therapeutic potential.
Conclusions:
- Overcoming curcumin's bioavailability challenges is crucial for its clinical translation.
- Innovative oral delivery strategies are essential to enhance curcumin's anticancer efficacy.
Related Concept Videos
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...